UY38233A - Agentes inhibidores para la tirosina cinasa de bruton - Google Patents

Agentes inhibidores para la tirosina cinasa de bruton

Info

Publication number
UY38233A
UY38233A UY0001038233A UY38233A UY38233A UY 38233 A UY38233 A UY 38233A UY 0001038233 A UY0001038233 A UY 0001038233A UY 38233 A UY38233 A UY 38233A UY 38233 A UY38233 A UY 38233A
Authority
UY
Uruguay
Prior art keywords
tyrosine kinase
inhibiting agents
bruton tyrosine
bruton
inhibiting
Prior art date
Application number
UY0001038233A
Other languages
English (en)
Inventor
T Hopkins Brian
Bin Ma
Robin Prince
Isaac Marx
Jurgen Schulz
Marta Nevalainen
Michael Dechantsreiter
Original Assignee
Biogen Ma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Ma Inc filed Critical Biogen Ma Inc
Publication of UY38233A publication Critical patent/UY38233A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se proporcionan compuestos de la fórmula (I) o sales farmacéuticamente aceptables de estos, y métodos para su uso y producción.
UY0001038233A 2018-05-14 2019-05-13 Agentes inhibidores para la tirosina cinasa de bruton UY38233A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862671053P 2018-05-14 2018-05-14

Publications (1)

Publication Number Publication Date
UY38233A true UY38233A (es) 2019-12-31

Family

ID=67002348

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001038233A UY38233A (es) 2018-05-14 2019-05-13 Agentes inhibidores para la tirosina cinasa de bruton

Country Status (9)

Country Link
US (1) US10899753B2 (es)
EP (1) EP3793994B1 (es)
JP (1) JP7359782B2 (es)
AR (1) AR115085A1 (es)
ES (1) ES2968222T3 (es)
MA (1) MA52629A (es)
TW (1) TW202016097A (es)
UY (1) UY38233A (es)
WO (1) WO2019222101A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020081514A1 (en) * 2018-10-15 2020-04-23 Biogen Ma Inc. Crystalline polymorphs of bruton's tyrosine kinase inhibitors
CN110627775A (zh) * 2019-10-24 2019-12-31 嘉兴特科罗生物科技有限公司 一种小分子化合物
JP2023508394A (ja) * 2019-12-23 2023-03-02 バイオジェン・エムエイ・インコーポレイテッド Ｂｔｋ阻害剤
CN112062691B (zh) * 2020-06-18 2022-12-09 中国农业科学院油料作物研究所 一种柠檬醛苯丁酸肟酯类化合物及其合成方法和应用
WO2022212893A1 (en) 2021-04-02 2022-10-06 Biogen Ma Inc. Combination treatment methods of multiple sclerosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US20150011751A1 (en) * 2012-03-09 2015-01-08 Carna Biosciences, Inc. Novel triazine derivative
US10280169B2 (en) 2013-12-11 2019-05-07 Biogen Ma Inc. Biaryl bruton's tyrosine kinase inhibitors
CN108947913A (zh) 2013-12-11 2018-12-07 比奥根Ma公司 可用于治疗人类肿瘤学、神经病学和免疫学疾病的联芳基化合物
WO2016201280A1 (en) 2015-06-10 2016-12-15 Biogen Ma Inc. Forms and compositions of biaryl inhibitors of bruton's tyrosine kinase

Also Published As

Publication number Publication date
JP2021523206A (ja) 2021-09-02
EP3793994B1 (en) 2023-08-23
US10899753B2 (en) 2021-01-26
JP7359782B2 (ja) 2023-10-11
EP3793994A1 (en) 2021-03-24
MA52629A (fr) 2021-03-24
WO2019222101A1 (en) 2019-11-21
AR115085A1 (es) 2020-11-25
TW202016097A (zh) 2020-05-01
US20190382394A1 (en) 2019-12-19
ES2968222T3 (es) 2024-05-08

Similar Documents

Publication Publication Date Title
UY38233A (es) Agentes inhibidores para la tirosina cinasa de bruton
CL2020000856A1 (es) Isoquinolinas como inhibidores de hpk1. (divisional solicitud 201902734)
EA201891024A1 (ru) Соединения-ингибиторы tank-связывающей киназы
CR20190124A (es) Inhibidores de ssao de aminopirimidina
EA201792214A1 (ru) Соединения замещенного хиназолина
EA201890307A1 (ru) Индазольные и азаиндазольные соединения как ингибиторы irak-4
EA201792116A1 (ru) Ингибитор янус-киназы
CO2018011408A2 (es) Compuestos de pirimidina como inhibidores de la quinasa jak
EA201890308A1 (ru) Замещенные азасоединения как ингибиторы irak-4
EA201991884A3 (ru) Ингибиторы g12c kras
EA201691302A1 (ru) Новые гетероциклические соединения
EA201592199A1 (ru) Производные бипиразола в качестве ингибиторов jak
ECSP21038390A (es) Compuestos, composiciones farmacéuticas y métodos de preparación de compuestos y de su uso como inhibidores de la cinasa atr
PE20151501A1 (es) Inhibidores de prmt5 y sus usos
MX2020003666A (es) Compuestos y composiciones para el tratamiento de trastornos hematologicos.
EA201992147A1 (ru) Ингибиторы тирозинкиназы брутона
EA201692268A1 (ru) Ингибиторы фосфатидилинозитол-3-киназы
CL2017003107A1 (es) Derivados de 2-(pirazolopiridin-3-il)pirimidina como inhibidores de jak
MX2018008815A (es) Inhibidores de tirosina quinasa de bruton.
EA201991700A1 (ru) Селективные ингибиторы jak1
CO2019012571A2 (es) Análogos de benzoazepina como agentes inhibidores de la tirosina cinasa de bruton
CL2023002223A1 (es) Inhibidores de cdk2 y métodos de uso de los mismos
CL2019001804A1 (es) Activador de nrf2.
EA202191051A1 (ru) Ингибитор аврора-киназы a для применения для лечения нейробластомы
CL2021000580A1 (es) Uso de inhibidores de la caseina quinasa 1 para el tratamiento de enfermedades vasculares.

Legal Events

Date Code Title Description
104 Application deemed to be withdrawn (no substantive examination fee paid)

Effective date: 20201203